Inflammatory Response Using Different Lipid Parenteral Nutrition Formulas in Children After Hematopoietic Stem Cell

María Auxiliadora Baena-Gómez1, María José de la Torre-Aguilar1, Concepción María Aguilera-García2

  • 1a Department of Paediatrics , Unit of Paediatric Research, Reina Sofia University Hospital, Maimónides Institute of Biomedical Research of Córdoba (IMIBIC), University of Córdoba , Córdoba , Spain.

Insights

Omega-3 fatty acids (n-3 FA) in parenteral nutrition (PN) did not alter inflammatory markers in children post-hematopoietic stem cell transplantation (HSCT) within 10 days. However, prolonged PN with fish oil-based lipid emulsions (LE) may reduce specific inflammatory cytokines.

Area of Science:

  • Nutrition and Immunology
  • Hematology and Transplantation

Background:

  • Nutritional support is crucial for hematopoietic stem cell transplantation (HSCT) patients.
  • Omega-3 fatty acids (n-3 FA) in parenteral nutrition (PN) may influence inflammatory responses.

Purpose of the Study:

  • To compare plasma cytokine levels in pediatric HSCT patients receiving PN with n-3 FA-containing lipid emulsions (LE) versus soybean oil-based LE.

Main Methods:

  • A randomized, double-blind, controlled trial involving 14 pediatric HSCT patients.
  • Patients received either fish oil or soybean oil LE in PN.
  • Plasma cytokines (IL-1β, IL-2, IL-6, IL-8, IL-10, TNF-α) were analyzed at baseline, Day 10, and post-PN.

Main Results:

  • No significant changes in interleukin levels were observed after 10 days of PN between groups or time points.
  • In patients requiring PN >21 days, IL-10 and TNF-α levels were significantly lower in the fish oil LE group (P ≤ 0.05).

Conclusions:

  • PN with fish oil or soybean oil LE for at least 10 days does not induce inflammatory changes in HSCT patients.
  • Extended PN using fish oil-based LE may potentially modulate the inflammatory response in this population.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
18.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
652